- Home
- TRVI vs SMWB Comparison
TRVI vs SMWB Comparison
Compare TRVI & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- SMWB
- Stock Information
- Founded
- TRVI 2011
- SMWB 2007
- Country
- TRVI United States
- SMWB Israel
- Employees
- TRVI N/A
- SMWB N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- SMWB Computer Software: Programming Data Processing
- Sector
- TRVI Health Care
- SMWB Technology
- Exchange
- TRVI Nasdaq
- SMWB Nasdaq
- Market Cap
- TRVI 725.7M
- SMWB 654.9M
- IPO Year
- TRVI 2019
- SMWB 2021
- Fundamental
- Price
- TRVI $6.55
- SMWB $8.28
- Analyst Decision
- TRVI Strong Buy
- SMWB Strong Buy
- Analyst Count
- TRVI 9
- SMWB 8
- Target Price
- TRVI $19.94
- SMWB $15.75
- AVG Volume (30 Days)
- TRVI 1.6M
- SMWB 525.3K
- Earning Date
- TRVI 08-07-2025
- SMWB 08-05-2025
- Dividend Yield
- TRVI N/A
- SMWB N/A
- EPS Growth
- TRVI N/A
- SMWB N/A
- EPS
- TRVI N/A
- SMWB N/A
- Revenue
- TRVI N/A
- SMWB $258,017,999.00
- Revenue This Year
- TRVI N/A
- SMWB $16.87
- Revenue Next Year
- TRVI N/A
- SMWB $14.96
- P/E Ratio
- TRVI N/A
- SMWB N/A
- Revenue Growth
- TRVI N/A
- SMWB 15.06
- 52 Week Low
- TRVI $2.36
- SMWB $5.71
- 52 Week High
- TRVI $7.48
- SMWB $17.64
- Technical
- Relative Strength Index (RSI)
- TRVI 61.06
- SMWB 53.68
- Support Level
- TRVI $5.41
- SMWB $8.53
- Resistance Level
- TRVI $6.08
- SMWB $9.19
- Average True Range (ATR)
- TRVI 0.32
- SMWB 0.44
- MACD
- TRVI 0.09
- SMWB 0.06
- Stochastic Oscillator
- TRVI 96.20
- SMWB 56.84
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About SMWB Similarweb Ltd.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.